Ocular Ischemic Syndrome (OIS) is a serious eye condition that happens when the eye does not get enough blood and oxygen for a long time. In simple words, the eye is “starving” for blood flow. Most of the time this reduced flow is caused by severe narrowing or blockage of the big neck arteries (the carotid arteries) that normally carry blood from the heart to the head, face, and eyes. When these arteries are narrowed, the pressure and volume of blood reaching the eye fall. The eye tissues—especially the retina (the light-sensitive film at the back of the eye) and the front of the eye (the iris and drainage angle)—begin to suffer from chronic, low-grade oxygen shortage. Over weeks to months, this shortage damages eye cells, triggers new but fragile blood vessels to grow (a stress reaction called “neovascularization”), and can raise eye pressure painfully. Without timely diagnosis and treatment of the underlying blood-flow problem, vision can decline and the eye can become painful.
In everyday language: OIS is a supply problem. The eye is healthy enough to see, but the “pipeline” that feeds it is kinked or blocked upstream. The job of the eye doctor is to spot the warning signs, test how bad the blood-flow problem is, and work with stroke and heart-blood-vessel specialists to fix the cause. Early diagnosis matters because OIS is not only an eye disease—it is also a whole-body risk signal that blood flow to the brain may be reduced, which can mean a higher chance of stroke.
How OIS happens
Blood leaves the heart and travels through the aorta. From the aortic arch, blood enters the common carotid arteries in the neck. Each common carotid splits into an internal and external carotid artery. The internal carotid artery feeds the ophthalmic artery, which feeds the eye. If the internal carotid is badly narrowed (stenosis) or blocked, the pressure head that drives blood into the eye drops. The eye tries to compensate by opening tiny vessels, stealing flow from neighboring routes, and growing new vessels. These new vessels are weak, leaky, and can clog the eye’s drain, driving up pressure and causing pain. The retina, which needs a constant rich supply of oxygen to work, becomes slow, swollen, and prone to bleeding. This slow, deep, and persistent lack of oxygen is different from a sudden artery plug (like a central retinal artery occlusion). OIS is usually chronic low-flow rather than sudden no-flow, and that difference shapes its symptoms, signs, and test results.
OIS most often appears in older adults who have the same risk factors that cause artery disease elsewhere: high blood pressure, diabetes, high cholesterol, smoking, kidney disease, and a history of heart or blood-vessel problems. It can also occur in younger patients when there is inflammation of large arteries, neck trauma, arterial dissection, or unusual blood disorders that make the blood too thick or too sticky. OIS can affect one eye or both eyes; when both eyes are involved, it strongly points to a widespread blood-flow problem.
Types of OIS
1) Carotid atherosclerotic OIS (most common).
This is the classic type. Fatty plaques and calcium narrow the internal carotid artery over many years. Flow falls slowly. The eye shows long-standing, low-pressure signs in the retina and sometimes new vessels in the front of the eye.
2) Inflammatory large-artery OIS.
Diseases like Giant Cell Arteritis (in older adults) or Takayasu arteritis (often in younger women) inflame the big arteries and narrow them quickly. The eye is starved even if cholesterol is normal. There are often body symptoms such as scalp tenderness, jaw pain with chewing, arm claudication, or low-grade fever.
3) Non-atherosclerotic structural OIS.
Causes include carotid dissection (a tear in the artery wall), fibromuscular dysplasia (abnormal artery wall development), and radiation-induced stenosis (late scarring and narrowing years after neck radiotherapy). The blood flow drops because the pipe is damaged, not because of a cholesterol plaque.
4) Low-output or low-pressure OIS.
Severe heart failure, massive blood loss, septic shock, or extreme low blood pressure can lower the driving force of blood for the whole body. The eye becomes an early victim because its tissues need steady high flow.
5) Hyperviscosity and hypercoagulability OIS.
When blood is too thick (hyperviscosity) or too prone to clot (hypercoagulable), flow through small and medium vessels slows and can be partially blocked. The eye’s microcirculation fails under the load.
6) OIS with anterior-segment neovascularization (“neovascular glaucoma pattern”).
Here the main feature is new vessels on the iris and in the angle. These vessels clog the drain, pressure rises, and pain becomes a major complaint. The retina is ischemic, but the front-of-eye changes dominate the picture.
7) Posterior-segment-predominant OIS (“venous stasis retinopathy”).
The main signs are at the back of the eye: narrowed arteries, dilated but not very tortuous veins, dot-blot hemorrhages in the mid-periphery, and slow dye filling on angiography. The front of the eye may still look quiet.
8) Unilateral versus bilateral OIS.
One eye is more common when one internal carotid is much worse than the other. Both eyes suggest widespread arterial disease or low systemic blood pressure and need urgent systemic assessment.
Common causes of OIS
Severe atherosclerotic stenosis of the internal carotid artery.
Fatty plaque and calcification narrow the artery lumen. Less blood reaches the ophthalmic artery, so the eye runs on “low pressure.”Complete occlusion (blockage) of the internal carotid artery.
If the artery is totally blocked, collateral detours may not supply enough pressure, and the eye becomes ischemic.High-grade stenosis of the common carotid artery or carotid bifurcation.
Even before the split into internal and external branches, a severe narrowing upstream lowers all downstream flow, including the eye’s supply.Aortic arch or brachiocephalic artery disease.
Major upstream blockages lower the pressure entering the carotid system, starving the eye despite normal smaller arteries.Carotid artery dissection.
A tear lets blood enter the artery wall, creating a flap and a false channel. The true channel narrows suddenly, reducing flow to the eye.Fibromuscular dysplasia.
Abnormal muscle and fiber in the artery wall create beaded-looking narrowings, which can limit flow to the ophthalmic artery in younger patients.Radiation-induced carotid stenosis.
Years after neck radiotherapy, scarring stiffens and narrows the carotid artery; the eye’s blood supply slowly falls.Giant Cell Arteritis (temporal arteritis).
Immune-driven inflammation thickens large-artery walls and closes their lumen quickly. The optic nerve and retina can suffer critical ischemia.Takayasu arteritis.
An inflammatory disease of the aorta and its branches that narrows carotids in young adults, causing chronic ocular hypoperfusion.External compression by neck tumors (e.g., carotid body tumor).
A mass can squeeze the artery from the outside, lowering flow to the eye without an internal plaque.Post-carotid surgery restenosis or complication.
After carotid endarterectomy or stenting, scar tissue or in-stent narrowing can re-reduce blood flow to the eye.Severe congestive heart failure.
When the heart cannot pump strongly, the pressure head for all organs falls. The eye’s delicate circulation is sensitive to this drop.Profound systemic hypotension (shock).
Sepsis, bleeding, or medication-induced low blood pressure can produce eye ischemia, especially in those with pre-existing carotid disease.Severe anemia.
Even if vessels are open, very low red blood cell levels mean the oxygen supply is poor. The retina struggles to meet its energy needs.Hyperviscosity syndromes (e.g., polycythemia vera).
Too many cells make blood thick. Thick blood flows sluggishly, starving capillaries in the retina and choroid.Waldenström macroglobulinemia or multiple myeloma.
Excess abnormal proteins thicken blood, slow flow, and can cause retinal hemorrhages and ischemia.Sickle cell disease.
Misshapen red cells block small vessels under low-oxygen stress, worsening downstream retinal perfusion.Antiphospholipid syndrome and other hypercoagulable states.
Excess clotting tendency plugs medium and small vessels, lowering effective perfusion to the eye.Major neck trauma.
Injury can tear or bruise the carotid artery, leading to dissection or thrombosis and low flow to the eye.Congenital carotid hypoplasia or aplasia.
Rarely, someone is born with an underdeveloped or missing carotid artery. If collateral pathways are weak, the eye can be ischemic.
Symptoms
Gradual, painless loss of vision in one eye.
Vision fades over weeks to months because the retina is under-nourished.Short “black-outs” of vision (amaurosis fugax).
Vision briefly goes dark like a curtain coming down, then recovers. This is a transient flow dip.Delayed recovery after bright light.
After looking at headlights or sunlight, vision takes a long time to return to normal because the retina’s energy stores are low.Dull, aching eye pain (“ocular angina”).
The eye can ache, especially with reading or in bright light, as the front-of-eye tissues complain about low oxygen.Headache or scalp tenderness (when due to Giant Cell Arteritis).
These body clues suggest an inflammatory cause of low blood flow.Jaw pain while chewing (jaw claudication; GCA clue).
Chewing raises muscle blood demand, and inflamed arteries cannot supply it.Worsening night vision.
Dim light stresses the retina’s energy use; with poor blood supply, night vision suffers first.Washed-out colors or poor contrast.
Color and contrast are early casualties of retinal ischemia.Peripheral vision loss or patches of missing vision.
Parts of the retina get more ischemic and stop working, creating field defects.Floaters.
Small spots or cobwebs can appear if there are tiny retinal bleeds or debris in the gel.Light sensitivity (photophobia).
Inflamed or ischemic front-of-eye tissues can become very sensitive to light.Red, painful eye with halos.
If new vessels clog the drain and raise pressure (neovascular glaucoma), the eye becomes red, painful, and haloed around lights.Tearing and irritation.
Surface dryness or inflammation can cause watery, gritty discomfort.Intermittent double vision or eye tiredness.
Ischemia rarely affects eye muscles or nerves enough to cause temporary misalignment and strain.General fatigue or transient weakness attacks.
Not an eye symptom, but often present when OIS comes from systemic low blood pressure or carotid disease; this clue pushes doctors to check the whole circulation.
Diagnostic tests
A) Physical examination
1) Vital signs and blood pressure in both arms.
What it is: Measuring heart rate and blood pressure, and sometimes checking pressure standing vs. lying down.
Why it helps: Low systemic pressure or big differences between arms suggest major vessel disease.
What OIS shows: Low or labile blood pressure can aggravate poor eye perfusion; unequal arm pressures can hint at upstream arterial narrowing.
2) Carotid artery auscultation (listening for bruits).
What it is: The clinician listens over the neck arteries with a stethoscope.
Why it helps: A “whooshing” sound (bruit) suggests turbulent flow through a narrowing.
What OIS shows: A loud bruit over the carotid on the side of the affected eye is a common clue to high-grade stenosis.
3) Temporal artery palpation and scalp exam.
What it is: Gently feeling the temples and scalp for tender, thickened arteries.
Why it helps: It screens for Giant Cell Arteritis, an urgent, treatable cause of ocular ischemia.
What OIS shows: Tender, ropey temporal arteries raise suspicion for GCA and trigger urgent lab tests and treatment.
4) Brief neurologic and cardiovascular exam.
What it is: Checking strength, speech, face symmetry, heart sounds, and pulses.
Why it helps: OIS often travels with brain and heart ischemia; exam findings may show broader vascular disease.
What OIS shows: Weak peripheral pulses, heart failure signs, or mini-stroke symptoms support a systemic cause.
B) Manual ophthalmic tests
5) Best-corrected visual acuity.
What it is: The standard letter chart test, with and without pinhole or refraction.
Why it helps: Establishes baseline function and monitors change.
What OIS shows: Reduced acuity that may fluctuate with lighting and fatigue, often worse in dim light.
6) Confrontation visual fields.
What it is: A bedside check for missing areas in side vision.
Why it helps: Field defects occur when parts of the retina are under-perfused.
What OIS shows: Patchy or generalized field loss, sometimes asymmetric.
7) Pupil exam for a relative afferent pupillary defect (RAPD).
What it is: Swinging flashlight test comparing pupil reactions.
Why it helps: Detects asymmetry in retinal/optic nerve input.
What OIS shows: An RAPD in the worse eye indicates significant retinal/optic nerve ischemia.
8) Slit-lamp biomicroscopy of the anterior segment.
What it is: Microscope exam of cornea, anterior chamber, and iris.
Why it helps: Looks for rubeosis iridis (new vessels on the iris), inflammation, and corneal edema.
What OIS shows: Fine new vessels on the iris or at the pupil margin, flare from protein leak, and sometimes a slightly inflamed, tender eye.
9) Intraocular pressure measurement (tonometry).
What it is: Measuring eye pressure with a gentle probe or air-puff device.
Why it helps: New vessels can block the drainage angle, raising pressure.
What OIS shows: Pressure can be normal early, then rise sharply with neovascular glaucoma, causing pain and redness.
10) Gonioscopy (examining the drainage angle).
What it is: A special contact lens lets the doctor see the angle where eye fluid drains.
Why it helps: Detects early new vessels creeping across the angle before pressure spikes.
What OIS shows: Delicate, abnormal blood vessels and scar tissue over the angle structures.
11) Dilated fundus examination.
What it is: Looking at the retina and optic nerve with lenses after pupil dilation.
Why it helps: The retina shows the history of perfusion.
What OIS shows: Narrowed arteries, moderately dilated but not corkscrew veins, mid-peripheral dot-blot hemorrhages, microaneurysms, sometimes rare cotton-wool spots, macular edema, and, in advanced cases, new vessels on the optic disc or retina.
C) Laboratory and pathological tests
12) Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
What it is: Blood tests of inflammation.
Why it helps: Very high values suggest Giant Cell Arteritis, which can cause ocular ischemia and demands urgent steroids.
What OIS shows: Markedly elevated ESR/CRP in the right clinical setting supports an inflammatory large-artery cause.
13) Fasting glucose and HbA1c.
What it is: Measures short- and long-term blood sugar control.
Why it helps: Diabetes accelerates large-artery disease and worsens ocular perfusion.
What OIS shows: Poor control adds weight to an atherosclerotic cause and shapes long-term risk reduction.
14) Lipid profile.
What it is: Cholesterol and triglyceride testing.
Why it helps: High LDL and triglycerides drive plaque growth.
What OIS shows: Abnormal lipids strengthen the case for carotid atherosclerosis as the main cause.
15) Complete blood count ± serum viscosity / hypercoagulability panel.
What it is: Counts of red cells, white cells, platelets; sometimes additional tests if indicated.
Why it helps: Detects anemia (low oxygen carry), polycythemia (thick blood), or clotting risks.
What OIS shows: Very low hemoglobin, very high hematocrit, or clotting abnormalities point to blood-related causes of low flow.
D) Electrodiagnostic tests
16) Full-field electroretinography (ERG).
What it is: A test that measures the retina’s electrical response to flashes of light.
Why it helps: Shows how well the whole retina is functioning under stress.
What OIS shows: Overall reduced responses, often with a relatively more affected inner-retinal signal, reflecting poor perfusion.
17) Visual evoked potential (VEP).
What it is: Measures the brain’s electrical response to visual patterns.
Why it helps: Detects slowed conduction from the eye to the brain when the retina and nerve are stressed.
What OIS shows: Delayed or reduced signals, supporting ischemic dysfunction.
E) Imaging tests
18) Fluorescein angiography (FA) of the retina.
What it is: A dye is injected into a vein, and a special camera tracks dye flow in the retinal vessels.
Why it helps: It directly shows how fast blood reaches and leaves the retina and choroid.
What OIS shows: Delayed choroidal filling, prolonged arteriovenous transit time, patchy non-perfusion, late staining of vessels, and sometimes leakage from new vessels.
19) Optical coherence tomography (OCT) ± OCT angiography (OCTA).
What it is: OCT is a non-contact scan that shows retinal layers; OCTA maps flow in small vessels without dye.
Why it helps: It quantifies swelling, thinning, and capillary density.
What OIS shows: Macular edema early; later, thinning of inner retinal layers; OCTA shows reduced capillary density in macula and peripapillary networks.
20) Carotid duplex ultrasound.
What it is: A noninvasive neck scan that uses sound waves to measure blood speed and detect narrowings.
Why it helps: It is the first-line test for carotid stenosis because it is fast, safe, and available.
What OIS shows: High velocities at narrowed segments, plaque features, and reduced downstream flow to the ophthalmic artery.
21) CT angiography (CTA) or MR angiography (MRA) of head and neck.
What it is: Cross-sectional imaging with contrast (CTA) or magnetic resonance (MRA) mapping the arteries.
Why it helps: It shows the exact location and severity of narrowings from the aortic arch to the skull base.
What OIS shows: High-grade internal carotid stenosis or occlusion, dissections, radiation changes, or anomalies that explain the eye’s low flow.
22) Digital subtraction angiography (DSA).
What it is: A catheter is placed into an artery to inject contrast directly and take detailed images.
Why it helps: It is the gold standard when noninvasive imaging is unclear or when planning surgery or stenting.
What OIS shows: Precise anatomy of plaques, collaterals, and ophthalmic artery flow; can also measure pressure gradients.
23) Echocardiography (heart ultrasound).
What it is: Ultrasound of the heart to assess pumping power and valves.
Why it helps: A weak heart lowers the pressure head; clots in the heart can also cause vascular problems.
What OIS shows: Reduced ejection fraction or valvular disease that contributes to ocular hypoperfusion.
Non-pharmacological treatments
Urgent risk-factor counseling and stroke-prevention plan: coordinate eye care with primary care/neurology/vascular surgery to reduce stroke and heart attack risk—the most important step. Mechanism: addresses the root problem (carotid disease). AHA JournalsJournal of Vascular Surgery
Smoking cessation: slows carotid plaque growth and improves endothelial function; NRT/behavioral support are often used.
Heart-healthy meal pattern (DASH/Mediterranean): lowers LDL, blood pressure, and inflammation, improving vessel health.
Regular aerobic activity (as cleared by your doctor): improves circulation and lipid/glucose control; start gentle (walking) and build up.
Blood pressure optimization (non-drug steps): salt reduction, weight loss, better sleep; protects vessel wall microcirculation.
Diabetes self-management: carb awareness, timing of meals, and CGM use if available; reduces endothelial injury.
Sleep apnea recognition and CPAP if needed: improves nocturnal oxygenation and lowers vascular events.
Hydration and avoiding long periods of head-down posture: helps ocular perfusion pressure in some patients.
Warmth and vasospasm avoidance (protect from cold triggers, avoid vasoconstricting decongestants): reduces transient vessel spasm.
Eye rest, glare control, and good lighting: eases strain when ischemic retina adapts slowly to light.
Head elevation for night pain: reduces venous congestion and pressure feelings.
Treat anemia or B12/folate deficiency with diet and medical care: improves oxygen delivery capacity.
Weight management: decreases BP, triglycerides, insulin resistance—key plaque drivers.
Stress reduction/sleep quality: helps BP and glucose variability.
Foot-to-neck vascular checkups (ABI, carotid ultrasound schedule): early detection of progression.
Medication adherence coaching for antiplatelets/statins prescribed by doctors: prevents stroke.
Avoid very sudden position changes (orthostatic drops can briefly worsen eye perfusion).
Avoid nicotine vapes and smokeless tobacco: same arterial harm as cigarettes.
Protective eyewear and UV filtering lenses: comfort and reduces photophobia; no cure, but improves function.
Education for family about stroke warning signs (FAST): rapid action saves brain and sight.
Drug treatments
(Classes, usual adult dosing/timing, purpose, how they work, key side effects. Doses are typical references—your doctor will individualize.)
Aspirin (antiplatelet): 81–325 mg once daily. Purpose: reduce stroke/MI risk in carotid disease. Mechanism: blocks platelet thromboxane. Side effects: stomach upset, bleeding risk. AHA Journals
Clopidogrel (antiplatelet): 75 mg once daily, sometimes with aspirin (short term) after stenting. Mechanism: P2Y12 inhibitor. Risks: bleeding, rare rash. Journal of Vascular Surgery
High-intensity statin (e.g., atorvastatin 40–80 mg nightly; rosuvastatin 20–40 mg nightly). Purpose: stabilize/regress plaque. Mechanism: lowers LDL and inflammation. Risks: muscle aches, rare liver enzyme rise. Journal of Vascular Surgery
ACE inhibitor or ARB (e.g., lisinopril 10–40 mg daily; losartan 50–100 mg daily). Purpose: BP control; endothelial protection. Risks: cough (ACEI), high potassium, kidney function changes.
Topical corticosteroid for anterior segment inflammation (e.g., prednisolone acetate 1% q.i.d. then taper). Purpose: reduce pain/flare from ischemia-related inflammation. Risks: IOP rise, cataract with long use. American Academy of Ophthalmology
Cycloplegic drops (e.g., atropine 1% b.i.d. during painful flare). Purpose: rest the iris/ciliary body; pain relief. Risks: light sensitivity, blurred near vision. American Academy of Ophthalmology
IOP-lowering drops for neovascular glaucoma (e.g., timolol 0.5% b.i.d., brimonidine 0.2% t.i.d., dorzolamide 2% t.i.d.). Purpose: lower eye pressure. Mechanisms: reduce aqueous production/increase outflow. Risks: slow heart rate/wheezing with beta-blockers; dry mouth/fatigue with alpha-agonists; tingling/metallic taste with carbonic anhydrase inhibitors.
Oral acetazolamide 250 mg q.i.d. or 500 mg ER b.i.d. (short term). Purpose: lower IOP quickly. Risks: tingling, fatigue, kidney stones; avoid in sulfa allergy.
Intravitreal anti-VEGF injections (e.g., bevacizumab 1.25 mg, ranibizumab 0.5 mg, aflibercept 2 mg; often monthly at first). Purpose: shrink abnormal iris/retinal vessels, help control IOP and inflammation while laser takes effect. Mechanism: blocks VEGF signaling that drives new vessel growth. Risks: very rare infection, small risk of IOP spike; often used with PRP. PMCAmerican Academy of OphthalmologyFrontiers
Intravitreal steroid (triamcinolone 1–2 mg) in select cases. Purpose: quell macular edema/inflammation. Risks: IOP rise, cataract—used selectively. American Academy of Ophthalmology
Dietary “molecular” supplements
Omega-3 EPA/DHA: 1–2 g/day. Function: improves lipid profile and endothelial function. Mechanism: anti-inflammatory eicosanoids.
Soluble fiber (psyllium): 5–10 g/day. Function: lowers LDL. Mechanism: bile acid binding.
Plant sterols/stanols: 1.5–2 g/day. Function: blocks cholesterol absorption.
Coenzyme Q10: 100–200 mg/day. Function: mitochondrial support; may help endothelial nitric oxide.
Magnesium: 200–400 mg/day (as tolerated). Function: BP and vascular tone support.
Vitamin D3: 1000–2000 IU/day (check levels). Function: systemic inflammation modulation.
Curcumin (with piperine): 500–1000 mg/day. Function: anti-inflammatory; may improve flow-mediated dilation.
L-arginine: 2–6 g/day divided. Function: nitric-oxide substrate for vasodilation.
Folate (0.4–1 mg) + B12 (1 mg) if elevated homocysteine. Function: lowers homocysteine, an endothelial toxin.
Potassium-rich foods (or supplement if safe): Function: BP control.
Note: Supplements are not a treatment for OIS. They can support risk-factor control alongside prescribed therapy.
Regenerative / stem-cell / immunity-boosting” concepts
There are no approved stem-cell drugs or “immunity boosters” for OIS. The following are research concepts or adjacent therapies and not standard of care. They should only be used in clinical trials or when a specialist advises for a different condition.
Endothelial progenitor cell therapy (investigational): infuses blood- or marrow-derived cells to promote re-endothelialization and microvascular repair. Status: early research in ischemic diseases; not approved for OIS.
Mesenchymal stem cells (investigational): aim to release trophic factors that reduce ischemic damage; risks and benefits not established for eyes like OIS.
Gene therapy to modulate VEGF/angiogenesis (investigational): long-acting anti-VEGF is being studied for other retinal diseases; not an OIS therapy today. ophthalmologyretina.org
Cilostazol (approved for other uses): 100 mg b.i.d. for PAD/stroke prevention in some regions; improves microcirculatory flow via PDE-3 inhibition—sometimes considered when vasospasm/platelet issues coexist; discuss risks (headache, palpitations).
Pentoxifylline (off-label microcirculation aid): 400 mg t.i.d. can reduce blood viscosity; mixed evidence; may help limb ischemia symptoms—ocular benefit is unproven.
Aggressive risk-factor medical therapy (statins, antiplatelets, BP/diabetes control): not “regenerative,” but the best proven way to stabilize plaque and protect the eye and brain right now. Journal of Vascular Surgery
Procedures and surgeries
Carotid endarterectomy (CEA): a vascular surgeon opens the carotid artery and removes the obstructing plaque. Why: For suitable patients with significant symptomatic stenosis, CEA lowers future stroke risk and may improve ocular perfusion. It is often preferred over transfemoral stenting in standard-risk patients. AHA JournalsMedscape
Carotid artery stenting (CAS): a stent is placed via a catheter to re-expand the narrowed segment. Why: Option for patients who are higher risk for open surgery or have anatomy favoring stenting; requires careful antiplatelet use. Journal of Vascular Surgery
Panretinal photocoagulation (PRP) laser: burns the oxygen-hungry peripheral retina to lower VEGF production, causing regression of abnormal iris/retinal vessels and helping prevent or control neovascular glaucoma. Often done in several sessions. The Journal of Medical Optometry (JoMO)AAO Journal
Intravitreal anti-VEGF injections (office procedure): medicine is injected into the eye to rapidly regress new vessels and reduce inflammation/IOP spikes while PRP takes effect. Often needs a series. PMC
Glaucoma surgery (e.g., tube shunt or cyclophotocoagulation): used when IOP remains high despite drops/laser. Why: Protect the optic nerve from pressure-related damage in NVG secondary to OIS. PMC
Practical preventions
Don’t smoke or vape nicotine.
Control blood pressure to targets set by your clinician.
Bring LDL cholesterol down (often with a statin).
Keep A1c in goal range if you have diabetes.
Maintain a healthy weight and waist size.
Be active most days (even a brisk walk helps).
Sleep 7–8 hours; treat sleep apnea.
Take prescribed antiplatelets exactly as directed.
Get regular eye exams and carotid follow-ups.
Know FAST stroke signs and call emergency services immediately if they occur.
When to see a doctor—right away vs. soon
Call emergency services now if you have sudden vision loss, one-sided weakness/numbness, face droop, or speech problems—these are stroke signs.
Urgent (same-day) eye care if you notice new eye pain, redness, halos, or a rapid decline in vision—these can be signs of neovascular glaucoma.
Soon (within days) if you have new or more frequent blackouts of vision, or a new carotid bruit is found, or your risk factors are uncontrolled.
What to eat and what to avoid
Eat more of these
Fatty fish (salmon, sardines) 2x/week for omega-3s.
Olive-oil-based veggies and legumes (Mediterranean-style plates).
High-fiber foods (oats, beans, berries) to lower LDL.
Leafy greens (spinach, kale) for nitrates and antioxidants.
Nuts (walnuts/almonds) in small handfuls for healthy fats.
Avoid or limit these
- Trans fats and partially hydrogenated oils (check labels).
- Excess salt (aim <5–6 g/day salt unless told otherwise).
- Refined sugars and ultra-processed snacks (spike glucose/triglycerides).
- Large alcohol intake (raises BP; if you drink, keep it light).
- Decongestants/energy drinks with vasoconstrictors (can worsen perfusion in sensitive people).
Frequently asked questions
1) Is OIS the same as a retinal artery occlusion?
No. A central retinal artery occlusion is a sudden blockage; OIS is a chronic low-flow state that can also cause acute events but usually builds over time. NCBI
2) Can OIS affect both eyes?
Yes, especially if both carotids or the aortic arch are diseased. One eye is often worse first.
3) Will new glasses fix it?
Glasses help refractive blur but not ischemia. Treating the carotid disease and the eye’s neovascularization is key.
4) What is amaurosis fugax?
A brief blackout of vision from reduced retinal blood flow—think of it as a TIA to the eye. It’s a stroke warning sign. NCBI
5) Do anti-VEGF injections cure OIS?
They do not cure the underlying carotid disease. They shrink abnormal vessels and help control pressure/inflammation while other treatments proceed. PMC
6) Is PRP laser painful, and why is it done?
Numbing drops are used; you may feel pressure or brief sting. PRP reduces retinal oxygen demand and lowers VEGF, which helps stop new abnormal vessels. The Journal of Medical Optometry (JoMO)
7) If I fix my carotid artery, will my vision return?
Some symptoms may improve, but damage already done to retina/optic nerve may not fully reverse. Carotid treatment mainly prevents future stroke and further damage. AHA Journals
8) Are glaucoma drops enough if pressure is high?
Drops help, but neovascular glaucoma from OIS often needs PRP, anti-VEGF, and sometimes surgery to protect the optic nerve. PMC
9) What’s the usual treatment order?
Stabilize the person (antiplatelet/statin/BP/diabetes), treat eye neovascularization (anti-VEGF + PRP), and address carotid disease (CEA/CAS) if you’re a candidate. Team care is best. American Academy of OphthalmologyAHA Journals
10) Can OIS come back after treatment?
Yes, if risk factors are uncontrolled or the carotid restenoses. Regular follow-up is essential.
11) Are prostaglandin glaucoma drops OK?
They may be used selectively, but doctors often start with aqueous-suppressing drops in neovascular glaucoma; choices are tailored to each eye.
12) Is steroid eye drop use dangerous?
They can raise IOP and promote cataract with long use, so they are used carefully and tapered as inflammation settles. American Academy of Ophthalmology
13) Are there vitamins that cure OIS?
No vitamin cures OIS. Diet and selected supplements help overall vascular health but do not replace medical/surgical care.
14) How urgent is a work-up if OIS is suspected?
Very urgent. The eye findings point to systemic carotid disease and elevated stroke risk; coordinated evaluation should happen quickly. American Academy of Ophthalmology
15) Where should my care team come from?
An ophthalmologist/retina specialist, a glaucoma specialist if needed, a vascular neurologist, and a vascular surgeon/interventionalist—plus your primary care to drive risk-factor control.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 16, 2025.
